38
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Hypofibrinolytic state and high thrombin generation may play a major role in sars‐cov2 associated thrombosis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Thirty percent of Covid‐19 patients admitted to intensive care units present with thrombotic complications despite thromboprophylaxis. Bed resting, obesity, hypoxia, coagulopathy, acute excessive inflammation are potential mechanisms reported by previous studies. Better understanding of the underlying mechanisms leading to thrombosis is crucial for developing more appropriate prophylaxis and treatment strategies.

          Objective

          We aimed to assess fibrinolytic activity and thrombin generation in 78 Covid‐19 patients.

          Patients and Methods

          Forty eight patients admitted to intensive care unit (ICU) and 30 patients admitted to the internal medicine department were included in the study. All patients received thromboprophylaxis. We measured fibrinolytic parameters (tPA, PAI‐1, TAFI, alpha2 anti‐plasmin, and tPA‐modified ROTEM), thrombin generation, and other coagulation tests (D‐dimer, fibrinogen, FVIII, antithrombin).

          Results and Conclusions

          We observed two key findings: a high thrombin generation capacity which remained within normal values despite heparin therapy and a hypofibrinolysis mainly associated with increased PAI‐1 levels. A modified ROTEM (TEM‐tPA) is able to detect both hypercoagulability and hypofibrinolysis simultaneously in Covid‐19 patients with thrombosis.

          Related collections

          Author and article information

          Contributors
          ydargaud@univ-lyon1.fr
          Journal
          J Thromb Haemost
          J. Thromb. Haemost
          10.1111/(ISSN)1538-7836
          JTH
          Journal of Thrombosis and Haemostasis
          John Wiley and Sons Inc. (Hoboken )
          1538-7933
          1538-7836
          15 July 2020
          : 10.1111/jth.15016
          Affiliations
          [ 1 ] Laboratoire d’Hematologie Groupement Hospitalier Est, Hospices Civils de Lyon Lyon France
          [ 2 ] Service de Medecine Intensive Reanimation Hopital Edouard Herriot Lyon France
          [ 3 ] Service de Medecine Interne Hopital Edouard Herriot Lyon France
          [ 4 ] Service de Reanimation Chirurgicale Hopital Edouard Herriot Lyon France
          [ 5 ] Service de Medecine Intensive Reanimation Centre Hospitalier Lyon Sud Lyon France
          [ 6 ] Service de réanimation chirurgicale Hopital de la Croix Rousse Lyon France
          [ 7 ] EA4609, Universite Claude Bernard Lyon 1 Lyon France
          [ 8 ] GEMMAT, Groupe d’Etude Multidisciplinaire en Maladies Thrombotiques Lyon France
          Author notes
          [*] [* ] Corresponding author

          Yesim Dargaud, MD, PhD, Hôpital Cardiologique Louis Pradel Unité d'Hémostase Clinique 28, Av Doyen Lépine F‐69500 Lyon, France

          Email: ydargaud@ 123456univ-lyon1.fr

          Author information
          https://orcid.org/0000-0002-4888-1463
          Article
          JTH15016
          10.1111/jth.15016
          7405476
          32668058
          877184ff-2e28-4836-8615-0d5b85384e84
          This article is protected by copyright. All rights reserved.

          This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

          History
          Page count
          Figures: 0, Tables: 0, Pages: 15, Words: 494
          Categories
          Brief Report
          Brief Report
          Custom metadata
          2.0
          accepted-manuscript
          Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.6 mode:remove_FC converted:05.08.2020

          Hematology
          fibrinolysis,plasminogen activator inhibitor 1,tissue plasminogen activator,tafi,thrombin generation,covid‐19

          Comments

          Comment on this article